137 related articles for article (PubMed ID: 10709095)
21. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors.
Soufir N; Queille S; Liboutet M; Thibaudeau O; Bachelier F; Delestaing G; Balloy BC; Breuer J; Janin A; Dubertret L; Vilmer C; Basset-Seguin N
Br J Dermatol; 2007 Mar; 156(3):448-53. PubMed ID: 17300232
[TBL] [Abstract][Full Text] [Related]
22. Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype.
Cleven AH; Zwartkruis E; Hogendoorn PC; Kroon HM; Briaire-de Bruijn I; Bovée JV
Histopathology; 2015 Oct; 67(4):483-90. PubMed ID: 25648524
[TBL] [Abstract][Full Text] [Related]
23. Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcoma.
Bae DK; Park YK; Chi SG; Lee CW; Unni KK
Oncol Res; 2000; 12(1):5-10. PubMed ID: 11061340
[TBL] [Abstract][Full Text] [Related]
24. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
25. Mutation analyses of the NFAT1 gene in chondrosarcomas and enchondromas.
Aoyama T; Nagayama S; Okamoto T; Hosaka T; Nakamata T; Nishijo K; Tsuboyama T; Nakayama T; Nakamura T; Toguchida J
Cancer Lett; 2002 Dec; 186(1):49-57. PubMed ID: 12183075
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of the p16INK4A gene by methylation is not a frequent event in sporadic ovarian carcinoma.
Brown I; Milner BJ; Rooney PH; Haites NE
Oncol Rep; 2001; 8(6):1359-62. PubMed ID: 11605066
[TBL] [Abstract][Full Text] [Related]
27. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
[TBL] [Abstract][Full Text] [Related]
29. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
32. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of p16 and Id1 status and endogenous reference genes in human chondrosarcoma by real-time PCR.
Asp J; Brantsing C; Lövstedt K; Benassi MS; Inerot S; Gamberi G; Picci P; Lindahl A
Int J Oncol; 2005 Dec; 27(6):1577-82. PubMed ID: 16273214
[TBL] [Abstract][Full Text] [Related]
34. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.
Bovée JV; Hogendoorn PC; Wunder JS; Alman BA
Nat Rev Cancer; 2010 Jul; 10(7):481-8. PubMed ID: 20535132
[TBL] [Abstract][Full Text] [Related]
35. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis.
Papachristou DJ; Goodman MA; Cieply K; Hunt JL; Rao UN
Hum Pathol; 2006 Jul; 37(7):890-8. PubMed ID: 16784990
[TBL] [Abstract][Full Text] [Related]
36. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
Marchetti A; Buttitta F; Pellegrini S; Bertacca G; Chella A; Carnicelli V; Tognoni V; Filardo A; Angeletti CA; Bevilacqua G
J Pathol; 1997 Feb; 181(2):178-82. PubMed ID: 9120722
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
[TBL] [Abstract][Full Text] [Related]
38. Mutation and methylation status of p53 gene promoter in human breast tumours.
Nayak BK; Das BR
Tumour Biol; 1999; 20(6):341-6. PubMed ID: 10567880
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of ephrin-A5, a gene product of normal cartilage, in chondrosarcoma.
Kalinski T; Röpke A; Sel S; Kouznetsova I; Röpke M; Roessner A
Hum Pathol; 2009 Dec; 40(12):1679-85. PubMed ID: 19695673
[TBL] [Abstract][Full Text] [Related]
40. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
